The Science of Longevity

Longevity science is moving from supplements and speculation to surgery and clinical trials. Nina leads the company that put the first stem-cell grown living bone into human beings — so when she talks about replacement parts for the human body, she's describing her own pipeline. From bone and cartilage today to more complex tissues tomorrow, she walks audiences through what regenerative medicine can genuinely deliver, on what timeline, and at what cost.

Beyond the science, this talk explores what extended healthspan means for how we work, insure, invest, and plan. When a 70-year-old knee can be regrown rather than replaced with titanium, entire industries reorganize. Nina brings a founder's pragmatism and an engineer's honesty to a field that badly needs both.